| Price | 7.60p on 01-05-2026 at 11:56:58 |
|---|---|
| Change | -1.15p -13.14% |
| Buy | 7.70p |
| Sell | 7.50p |
| Last Trade: | Buy 20,000.00 at 7.615p |
| Day's Volume: | 9,828,372 |
| Last Close: | 8.75p |
| Open: | 8.85p |
| ISIN: | GB00BYV81293 |
| Day's Range | 7.15p - 8.85p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £81.20m |
| VWAP: | 7.687003p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 20,000 | 7.615p | Ordinary |
12:56:57 - 01-May-26 |
| Buy* | 8,398 | 7.62p | Ordinary |
12:38:21 - 01-May-26 |
| Buy* | 6,496 | 7.62p | Ordinary |
12:26:45 - 01-May-26 |
| Sell* | 15,635 | 7.552p | Ordinary |
11:59:13 - 01-May-26 |
| Buy* | 6,475 | 7.64p | Ordinary |
11:46:39 - 01-May-26 |
| Sell* | 39,525 | 7.59p | Ordinary |
11:44:08 - 01-May-26 |
| Sell* | 28,763 | 7.5306p | Ordinary |
11:08:48 - 01-May-26 |
| Sell* | 20,000 | 7.59p | Ordinary |
11:04:38 - 01-May-26 |
| Sell* | 1,000 | 7.58p | Ordinary |
10:59:12 - 01-May-26 |
| Buy* | 7,601 | 7.70p | Ordinary |
10:59:11 - 01-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
